If you’ve been diagnosed with CTCL, it is vital that you take an active role in your treatment decisions.
That means, first of all, talking to your doctor. Your doctor is an important source of information about CTCL and all of the therapeutic options available, including THERAKOS™ Photopheresis in particular. So ask questions, discuss your concerns, and add to your understanding however you can.
It’s not unusual to arrive at your doctor’s office and then forget what you wanted to ask. Think about writing down your questions ahead of time and bringing them with you. This just might help you better organize your thoughts in what is surely a difficult situation.
Specially designed for medical professionals to use in their practice.
See top Opinion Leaders address FAQs about THERAKOS™ Photopheresis
Methoxsalen Sterile Solution is indicated for extracorporeal administration with the THERAKOS™ UVAR XTS® or THERAKOS™ CELLEX® Photopheresis System in the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL) that is unresponsive to other forms of treatment.
Methoxsalen is not appropriate for patients who have had a reaction to psoralen compounds, patients who have had a light sensitive disease, or patients with an absence of one or both lenses of the eye.
THERAKOS™ Photopheresis is not appropriate for patients who cannot tolerate blood volume changes or patients with blood clotting disorders. See Important Safety Information for additional details.